In this article

PFE

Follow your favorite stocks CREATE FREE ACCOUNT

Pfizer on Tuesday hiked its full-year adjusted profit guidance on cost cuts and its strong business performance this year.

The company also reported second-quarter results that topped Wall Street's estimates for the period, as revenue from its Covid products and some other drugs jumped.

Shares of Pfizer rose more than 4% on Tuesday.

Pfizer now expects full-year adjusted profit to come in between $2.90 and $3.10, up from previous guidance of $2.80 to $3 per share. The company maintained its 2025 revenue forecast of $61 billion to $64 billion.

"We raised our full-year 2025 Adjusted diluted EPS guidance, demonstrating confidence in our ability to execute against our strategic priorities and deliver strong r

See Full Page